Psychedelic-assisted therapy for
cancer, PTSD, depression, and trauma.
Advancing Psychedelic Therapy Through Clinical Research
Our Mission
Sunstone in the News
An overview of psychedelic + related compounds, including proposed mechanisms of action, physical and physiological risks, and investigational clinical applications. […]
Journal of Psychopharmacology, Jan 2022.
Journal of Clinical Oncology, June 2022.
Journal of Affective Disorders, Dec 2022.
Select Agrawal M., Emanuel E., Richards B., et al. “Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.” JAMA Oncology, April 2023.
Agrawal M., Richards W., Beaussant Y., et al. “Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder.” Cancer, July 2023.
Gramling R., Bennett E., Curtis K., et al. “Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.” Journal of Palliative Medicine, August 2023.
Marseille E., Stauffer C., Agrawal M., et al. “Group psychedelic therapy: empirical estimates of cost-savings and improved access.” Front. Psychiatry, Dec. 2023.
Beaussant Y., Tarbi E., Nigam K., et al. “Acceptability of psilocybin-assisted group therapy in patients with cancer and MDD.” Cancer, Dec 2023.
Ehrenkranz R., Agrawal M., Penberthy J., Yaden., D. “Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.” International Review of Psychiatry, May 2024.